You have free access to this content

Alimentary Pharmacology & Therapeutics

Cover image for Vol. 42 Issue 5

September 2015

Volume 42, Issue 5

Pages 491–635

  1. SYSTEMATIC REVIEW WITH META-ANALYSIS

    1. Top of page
    2. SYSTEMATIC REVIEW WITH META-ANALYSIS
    3. RANDOMISED CLINICAL TRIAL
    4. CHEMOTHERAPY AND THE INTESTINAL MICROBIOME
    5. INFLAMMATORY BOWEL DISEASE
    6. VIRAL HEPATITIS
    7. HEPATOLOGY
    8. GLUCOCORTICOIDS AND ULCER BLEEDING
    9. RESPIRATORY INFECTIONS AND ESOMEPRAZOLE
    10. GERD
    11. INVITED EDITORIALS
    12. LETTERS TO THE EDITORS
    1. You have free access to this content
  2. RANDOMISED CLINICAL TRIAL

    1. Top of page
    2. SYSTEMATIC REVIEW WITH META-ANALYSIS
    3. RANDOMISED CLINICAL TRIAL
    4. CHEMOTHERAPY AND THE INTESTINAL MICROBIOME
    5. INFLAMMATORY BOWEL DISEASE
    6. VIRAL HEPATITIS
    7. HEPATOLOGY
    8. GLUCOCORTICOIDS AND ULCER BLEEDING
    9. RESPIRATORY INFECTIONS AND ESOMEPRAZOLE
    10. GERD
    11. INVITED EDITORIALS
    12. LETTERS TO THE EDITORS
    1. You have full text access to this OnlineOpen article
      Randomised clinical trial: a placebo-controlled study of intravenous golimumab induction therapy for ulcerative colitis (pages 504–514)

      P. Rutgeerts, B. G. Feagan, C. W. Marano, L. Padgett, R. Strauss, J. Johanns, O. J. Adedokun, C. Guzzo, H. Zhang, J.-F. Colombel, W. Reinisch, P. R. Gibson, W. J. Sandborn and for the PURSUIT-IV study group

      Article first published online: 29 JUN 2015 | DOI: 10.1111/apt.13291

  3. CHEMOTHERAPY AND THE INTESTINAL MICROBIOME

    1. Top of page
    2. SYSTEMATIC REVIEW WITH META-ANALYSIS
    3. RANDOMISED CLINICAL TRIAL
    4. CHEMOTHERAPY AND THE INTESTINAL MICROBIOME
    5. INFLAMMATORY BOWEL DISEASE
    6. VIRAL HEPATITIS
    7. HEPATOLOGY
    8. GLUCOCORTICOIDS AND ULCER BLEEDING
    9. RESPIRATORY INFECTIONS AND ESOMEPRAZOLE
    10. GERD
    11. INVITED EDITORIALS
    12. LETTERS TO THE EDITORS
    1. You have free access to this content
      Chemotherapy-driven dysbiosis in the intestinal microbiome (pages 515–528)

      E. Montassier, T. Gastinne, P. Vangay, G. A. Al-Ghalith, S. Bruley des Varannes, S. Massart, P. Moreau, G. Potel, M. F. de La Cochetière, E. Batard and D. Knights

      Article first published online: 6 JUL 2015 | DOI: 10.1111/apt.13302

  4. INFLAMMATORY BOWEL DISEASE

    1. Top of page
    2. SYSTEMATIC REVIEW WITH META-ANALYSIS
    3. RANDOMISED CLINICAL TRIAL
    4. CHEMOTHERAPY AND THE INTESTINAL MICROBIOME
    5. INFLAMMATORY BOWEL DISEASE
    6. VIRAL HEPATITIS
    7. HEPATOLOGY
    8. GLUCOCORTICOIDS AND ULCER BLEEDING
    9. RESPIRATORY INFECTIONS AND ESOMEPRAZOLE
    10. GERD
    11. INVITED EDITORIALS
    12. LETTERS TO THE EDITORS
    1. You have free access to this content
    2. You have free access to this content
      Systematic analysis of factors associated with progression and regression of ulcerative colitis in 918 patients (pages 540–548)

      E. Safroneeva, S. Vavricka, N. Fournier, F. Seibold, C. Mottet, A. Nydegger, J. Ezri, A. Straumann, G. Rogler, A. M. Schoepfer and on behalf of the Swiss IBD Cohort Study Group

      Article first published online: 6 JUL 2015 | DOI: 10.1111/apt.13307

    3. You have free access to this content
  5. VIRAL HEPATITIS

    1. Top of page
    2. SYSTEMATIC REVIEW WITH META-ANALYSIS
    3. RANDOMISED CLINICAL TRIAL
    4. CHEMOTHERAPY AND THE INTESTINAL MICROBIOME
    5. INFLAMMATORY BOWEL DISEASE
    6. VIRAL HEPATITIS
    7. HEPATOLOGY
    8. GLUCOCORTICOIDS AND ULCER BLEEDING
    9. RESPIRATORY INFECTIONS AND ESOMEPRAZOLE
    10. GERD
    11. INVITED EDITORIALS
    12. LETTERS TO THE EDITORS
    1. You have free access to this content
    2. You have free access to this content
      Hepatitis E virus in patients with decompensated chronic liver disease: a prospective UK/French study (pages 574–581)

      H. Blasco-Perrin, R. G. Madden, A. Stanley, C. Crossan, J. G. Hunter, L. Vine, K. Lane, N. Devooght-Johnson, C. Mclaughlin, J. Petrik, B. Stableforth, H. Hussaini, M. Phillips, J. M. Mansuy, E. Forrest, J. Izopet, O. Blatchford, L. Scobie, J. M. Peron and H. R. Dalton

      Article first published online: 14 JUL 2015 | DOI: 10.1111/apt.13309

  6. HEPATOLOGY

    1. Top of page
    2. SYSTEMATIC REVIEW WITH META-ANALYSIS
    3. RANDOMISED CLINICAL TRIAL
    4. CHEMOTHERAPY AND THE INTESTINAL MICROBIOME
    5. INFLAMMATORY BOWEL DISEASE
    6. VIRAL HEPATITIS
    7. HEPATOLOGY
    8. GLUCOCORTICOIDS AND ULCER BLEEDING
    9. RESPIRATORY INFECTIONS AND ESOMEPRAZOLE
    10. GERD
    11. INVITED EDITORIALS
    12. LETTERS TO THE EDITORS
    1. You have free access to this content
      Novel association between serum pentraxin-2 levels and advanced fibrosis in well-characterised patients with non-alcoholic fatty liver disease (pages 582–590)

      E. C. Verna, J. Patel, R. Bettencourt, P. Nguyen, C. Hernandez, M. A. Valasek, T. Kisselva, D. A. Brenner and R. Loomba

      Article first published online: 29 JUN 2015 | DOI: 10.1111/apt.13292

    2. You have free access to this content
  7. GLUCOCORTICOIDS AND ULCER BLEEDING

    1. Top of page
    2. SYSTEMATIC REVIEW WITH META-ANALYSIS
    3. RANDOMISED CLINICAL TRIAL
    4. CHEMOTHERAPY AND THE INTESTINAL MICROBIOME
    5. INFLAMMATORY BOWEL DISEASE
    6. VIRAL HEPATITIS
    7. HEPATOLOGY
    8. GLUCOCORTICOIDS AND ULCER BLEEDING
    9. RESPIRATORY INFECTIONS AND ESOMEPRAZOLE
    10. GERD
    11. INVITED EDITORIALS
    12. LETTERS TO THE EDITORS
    1. You have free access to this content
      Short-term use of glucocorticoids and risk of peptic ulcer bleeding: a nationwide population-based case-crossover study (pages 599–606)

      C.-L. Tseng, Y.-T. Chen, C.-J. Huang, J.-C. Luo, Y.-L. Peng, D.-F Huang, M.-C. Hou, H.-C. Lin and F.-Y. Lee

      Article first published online: 22 JUN 2015 | DOI: 10.1111/apt.13298

  8. RESPIRATORY INFECTIONS AND ESOMEPRAZOLE

    1. Top of page
    2. SYSTEMATIC REVIEW WITH META-ANALYSIS
    3. RANDOMISED CLINICAL TRIAL
    4. CHEMOTHERAPY AND THE INTESTINAL MICROBIOME
    5. INFLAMMATORY BOWEL DISEASE
    6. VIRAL HEPATITIS
    7. HEPATOLOGY
    8. GLUCOCORTICOIDS AND ULCER BLEEDING
    9. RESPIRATORY INFECTIONS AND ESOMEPRAZOLE
    10. GERD
    11. INVITED EDITORIALS
    12. LETTERS TO THE EDITORS
    1. You have free access to this content
  9. GERD

    1. Top of page
    2. SYSTEMATIC REVIEW WITH META-ANALYSIS
    3. RANDOMISED CLINICAL TRIAL
    4. CHEMOTHERAPY AND THE INTESTINAL MICROBIOME
    5. INFLAMMATORY BOWEL DISEASE
    6. VIRAL HEPATITIS
    7. HEPATOLOGY
    8. GLUCOCORTICOIDS AND ULCER BLEEDING
    9. RESPIRATORY INFECTIONS AND ESOMEPRAZOLE
    10. GERD
    11. INVITED EDITORIALS
    12. LETTERS TO THE EDITORS
    1. You have free access to this content
      Electrical stimulation therapy of the lower oesophageal sphincter for refractory gastro-oesophageal reflux disease – interim results of an international multicentre trial (pages 614–625)

      W. F. W. Kappelle, A. J. Bredenoord, J. M. Conchillo, J. P. Ruurda, N. D. Bouvy, M. I. van Berge Henegouwen, P. W. Chiu, M. Booth, A. Hani, D. N. Reddy, A. Bogte, A. J. P. M. Smout, J. C. Wu, A. Escalona, M. A. Valdovinos, G. Torres-Villalobos and P. D. Siersema

      Article first published online: 8 JUL 2015 | DOI: 10.1111/apt.13306

  10. INVITED EDITORIALS

    1. Top of page
    2. SYSTEMATIC REVIEW WITH META-ANALYSIS
    3. RANDOMISED CLINICAL TRIAL
    4. CHEMOTHERAPY AND THE INTESTINAL MICROBIOME
    5. INFLAMMATORY BOWEL DISEASE
    6. VIRAL HEPATITIS
    7. HEPATOLOGY
    8. GLUCOCORTICOIDS AND ULCER BLEEDING
    9. RESPIRATORY INFECTIONS AND ESOMEPRAZOLE
    10. GERD
    11. INVITED EDITORIALS
    12. LETTERS TO THE EDITORS
    1. You have free access to this content
    2. You have free access to this content
  11. LETTERS TO THE EDITORS

    1. Top of page
    2. SYSTEMATIC REVIEW WITH META-ANALYSIS
    3. RANDOMISED CLINICAL TRIAL
    4. CHEMOTHERAPY AND THE INTESTINAL MICROBIOME
    5. INFLAMMATORY BOWEL DISEASE
    6. VIRAL HEPATITIS
    7. HEPATOLOGY
    8. GLUCOCORTICOIDS AND ULCER BLEEDING
    9. RESPIRATORY INFECTIONS AND ESOMEPRAZOLE
    10. GERD
    11. INVITED EDITORIALS
    12. LETTERS TO THE EDITORS
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
    5. You have free access to this content
    6. You have free access to this content
    7. You have free access to this content
      Letter: serum vitamin D levels in primary biliary cirrhosis (pages 633–634)

      T. Bruns, C. Kittler, S. Stengel, P. J. Trivedi and A. Stallmach

      Article first published online: 3 AUG 2015 | DOI: 10.1111/apt.13305

    8. You have free access to this content

SEARCH

SEARCH BY CITATION